- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06475716
Guided Internet-based Trauma-focused CBT Programme for Post-traumatic Stress Disorder 'Spring' (SPRING-LT)
June 25, 2024 updated by: Vilnius University
Efficacy of a Guided Internet-based Trauma-focused CBT Intervention 'Spring' for ICD-11 Posttraumatic Stress Disorder Symptoms: A Randomized Controlled Trial
The main aim of the study is to evaluate the efficacy of the Lithuanian version of the internet-based guided self-help programme (Spring) in reducing ICD-11 PTSD symptoms.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Detailed Description
Spring is an online guided self-help programme for the reduction of posttraumatic stress disorder symptoms.
It is based on the principles of trauma-focused cognitive behavioral therapy and consists of 8 steps covering psychoeducation, grounding techniques, management of anxiety, behavioral activation, imaginal exposure, cognitive restructuring, in vivo exposure, and prevention of relapse.
The user of the programme also receives up to 3 hours of therapist guidance.
Originally Spring was developed by the research team at Cardiff University.
In the current study, the most recent second version of the Spring programme adapted to the Lithuanian population will be used.
The main aim of the study is to evaluate the efficacy of the Lithuanian version of the Spring programme in reducing ICD-11 posttraumatic stress disorder symptoms.
Study Type
Interventional
Enrollment (Estimated)
50
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Odeta Gelezelyte, Dr.
- Phone Number: +37052686952
- Email: odeta.gelezelyte@fsf.vu.lt
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Aged 18 years or over
- Ability to read and write fluently in Lithuanian
- Have regular access to a device with an internet connection to use the programme
- Provide informed consent for participation
- Experience PTSD symptoms followed by a non-prolonged and non-repetitive traumatic experience as measured by the ITI
Exclusion Criteria:
- Regularly seeing a therapist or counsellor for mental health issues
- Change in psychotropic medication in the last month
- CPTSD diagnosis
- Psychosis
- Severe suicide risk
- Substance dependence
- Experiencing ongoing threat
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Immediate treatment group
The immediate treatment group will receive the intervention immediately after randomization.
The intervention includes using an online guided self-help programme Spring that is based on the principles of trauma-focused cognitive behavioral therapy and consists of 8 steps.
The user of the programme also receives up to 3 hours of guidance by a trained therapist.
|
Spring is an online guided self-help programme based on the principles of trauma-focused cognitive behavioral therapy and consists of 8 steps designed for delivery over 8 weeks.
The steps cover psychoeducation, grounding techniques, management of anxiety, behavioral activation, imaginal exposure, cognitive restructuring, in vivo exposure, and prevention of relapse.
The user of the programme also receives up to 3 hours of therapist guidance.
|
Active Comparator: Delayed treatment control group
The delayed treatment group will receive the same intervention as the immediate treatment group, but 24 weeks after randomization.
The intervention includes using an online guided self-help programme Spring that is based on the principles of trauma-focused cognitive behavioral therapy and consists of 8 steps.
The user of the programme also receives up to 3 hours of guidance by a trained therapist.
|
Spring is an online guided self-help programme based on the principles of trauma-focused cognitive behavioral therapy and consists of 8 steps designed for delivery over 8 weeks.
The steps cover psychoeducation, grounding techniques, management of anxiety, behavioral activation, imaginal exposure, cognitive restructuring, in vivo exposure, and prevention of relapse.
The user of the programme also receives up to 3 hours of therapist guidance.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in International Trauma Interview (ITI) PTSD score post-treatment
Time Frame: baseline; 10 weeks after randomization
|
The ITI is a semi-structured clinical interview for the assessment of symptoms of ICD-11 posttraumatic stress disorder.
The total ITI score measuring symptoms of PTSD may range from 0 to 24.
Higher scores indicate greater symptom severity.
|
baseline; 10 weeks after randomization
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in International Trauma Interview (ITI) PTSD score at a three-month follow-up
Time Frame: baseline; 22 weeks after randomization
|
The ITI is a semi-structured clinical interview for the assessment of symptoms of ICD-11 posttraumatic stress disorder and disturbances is self organization (DSO).
The total ITI score measuring DSO symptoms may range from 0 to 24.
Higher scores indicate greater symptom severity.
|
baseline; 22 weeks after randomization
|
Change in International Trauma Interview (ITI) DSO score
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization
|
The ITI is a semi-structured clinical interview for the assessment of symptoms of ICD-11 posttraumatic stress disorder and disturbances is self organization (DSO).
The total ITI score measuring DSO symptoms may range from 0 to 24.
Higher scores indicate greater symptom severity.
|
baseline; 10 weeks after randomization; 22 weeks after randomization
|
Change in International Trauma Questionnaire (ITQ) score
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
The ITQ is a self-report questionnaire for the assessment of symptoms of ICD-11 posttraumatic stress disorder and complex posttraumatic stress disorder.
The overall ITQ score ranges from 0 to 24.
Higher scores indicate greater symptom severity.
|
baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
Change in International Depression Questionnaire (IDQ) score
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
The IDQ is a self-report questionnaire for the assessment of ICD-11 depression symptoms.
Possible range of scores varies from 0 to 36.
Higher scores indicate greater symptom severity.
|
baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
Change in International Anxiety Questionnaire (IAQ) score
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
The IAQ is a self-report questionnaire for the assessment of ICD-11 anxiety symptoms.
Possible range of scores varies from 0 to 32.
Higher scores indicate greater symptom severity.
|
baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
Change in World Health Organization Well-Being Index (WHO-5) score
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
The WHO-5 is a five-item self-report scale that assesses subjective psychological well-being.
The range of the final WHO-5 index score ranges from 0 to 100, with higher scores indicating better well-being.
|
baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
Change in Brief Version of the Posttraumatic Cognitions Inventory (PTCI-9)
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
PTCI-9 is a self-report measure assessing posttraumatic appraisals.
The final score ranges from 9 to 63.
Higher scale scores indicate stronger endorsement of negative cognitions.
|
baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
Change in Trauma Related Shame Inventory - Short Form (TRSI-SF)
Time Frame: baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
TRSI-SF is a self-report scale measuring trauma-related shame.
The final score ranges from 0 to 30.
Higher scores indicate higher levels of shame.
|
baseline; 10 weeks after randomization; 22 weeks after randomization; 32 weeks after randomization (delayed treatment group only)
|
Patient satisfaction questionnaire (ZUF-8)
Time Frame: 10 weeks after randomization (immediate treatment group only); 32 weeks after randomization (delayed treatment group only)
|
ZUF-8 is a self-report instrument for measuring patient satisfaction with the treatment/service received.
The final score ranges from 8 to 32.
Higher scores indicate stronger satisfaction with treatment.
|
10 weeks after randomization (immediate treatment group only); 32 weeks after randomization (delayed treatment group only)
|
Working Alliance Inventory for guided Internet Interventions (WAI-I)
Time Frame: 5 and 10 weeks after randomization (immediate treatment group only); 27 and 32 weeks after randomization (delayed treatment group only)
|
WAI-I is a self-report instrument to assess the working alliance in the context of guided Internet interventions.
The overall WAI-I score ranges from 12 to 60. Higher scores reflect stronger working alliance.
|
5 and 10 weeks after randomization (immediate treatment group only); 27 and 32 weeks after randomization (delayed treatment group only)
|
Readiness for Therapy Questionnaire (RTQ)
Time Frame: Baseline (before start using the intervention programme)
|
RTQ is a self-report measure of clients' readiness for change.
The final score ranges from 0 to 24.
Higher scores indicate greater readiness for therapy.
|
Baseline (before start using the intervention programme)
|
The Treatment Expectation Questionnaire (TEX-Q)
Time Frame: Baseline (before start using the intervention programme)
|
TEX-Q is a self-report assessment of clients' treatment expectations.
The TEX-Q consists of 6 subscales: treatment benefit, positive impact, adverse events, negative impact, process, behavior control.
Each item of the TEX-Q subscales is measured on a scale from 0 to 10.
The mean score can range from 0 to 10.
The overall score of TEX-Q is determined by calculating the mean with a reversal of the harm expectation subscales; higher values indicate more positive treatment expectations.
|
Baseline (before start using the intervention programme)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Odeta Gelezelyte, Dr., Vilnius University, Centre for Psychotraumatology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 10, 2024
Primary Completion (Estimated)
December 20, 2025
Study Completion (Estimated)
December 20, 2025
Study Registration Dates
First Submitted
June 17, 2024
First Submitted That Met QC Criteria
June 25, 2024
First Posted (Estimated)
June 26, 2024
Study Record Updates
Last Update Posted (Estimated)
June 26, 2024
Last Update Submitted That Met QC Criteria
June 25, 2024
Last Verified
June 1, 2024
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- S-MIP-23-14
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Anonymized datasets used during the study will be available from the corresponding author upon reasonable request.
IPD Sharing Time Frame
After the main results of the study are published.
IPD Sharing Access Criteria
Anonymized datasets used during the study will be available from the corresponding author upon reasonable request.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Posttraumatic Stress Disorder
-
University Hospital, ToursCompletedPostTraumatic Stress DisorderFrance
-
The University of Texas Health Science Center at...University of Pennsylvania; Brooke Army Medical Center; C.R.Darnall Army Medical... and other collaboratorsCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Icahn School of Medicine at Mount SinaiCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Berlin Center for the Treatment of Torture VictimsCompletedPosttraumatic Stress Disorder (PTSD)Germany
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
Michael E. DeBakey VA Medical CenterSouth Central VA Mental Illness Research, Education & Clinical CenterCompletedPosttraumatic Stress Disorder (PTSD)United States
-
TEMPVA Research Group, Inc.C.R.Darnall Army Medical Center; VA Boston Healthcare System; Central Texas Veterans...UnknownPosttraumatic Stress Disorder, Combat-relatedUnited States
-
VA Office of Research and DevelopmentCompletedPosttraumatic Stress Disorder (PTSD)United States
-
VA Office of Research and DevelopmentCompleted
-
Yale UniversityNational Center for PTSDCompletedPosttraumatic Stress Disorder (PTSD)United States
Clinical Trials on Internet-based guided programme Spring
-
Anadolu UniversityNot yet recruitingMental Health Issue
-
University of EdinburghNHS TaysideCompletedAnorexia Nervosa | Bulimia Nervosa | Binge Eating Disorder | Other Specified Feeding or Eating DisorderUnited Kingdom
-
Eskisehir Osmangazi UniversityUnknown
-
Anadolu UniversityNot yet recruitingMental Health Issue
-
Anadolu UniversityEskisehir Osmangazi UniversityNot yet recruiting
-
Örebro County CouncilSchool of Law, Psychology and Social Work, Örebro UniversityCompletedBipolar Disorder, Type IISweden
-
Gerhard AnderssonCompleted
-
Linkoeping UniversityUppsala UniversityCompletedBack Pain Lower Back ChronicSweden
-
Johannes Gutenberg University MainzLinkoeping UniversityCompleted
-
University of BernUniversitätsklinikum Hamburg-EppendorfCompletedSchizophrenia | Hallucinations | Persecutory DelusionGermany, Switzerland